Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

International Breast Cancer Intervention Study

Next Previous
Trial Profile

International Breast Cancer Intervention Study

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Dec 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Breast cancer; Ductal carcinoma
  • Focus Registrational; Therapeutic Use
  • Acronyms IBIS-II; IBIS-II Bone; IBIS-II-Prevention

    • Most Recent Events

    • 05 Dec 2023 Results assessing the effects of serum oestradiol and testosterone concentrations on the efficacy of the aromatase inhibitor anastrozole for the prevention of breast cancer in postmenopausal women at high risk, published in the Lancet Oncology.
    • 05 Oct 2021 Status changed from active, no longer recruiting to completed.
    • 22 Jan 2021 Results of the BMD substudy assessing Off-treatment bone mineral density changes in postmenopausal women published in the British Journal of Cancer
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Legal
Back to top